One Bio News Today

One Bio entered the market last month on a mission to end inflammatory disease and decimate food waste by making odorless, colorless and tasteless fiber from salvaged agricultural byproducts.

With a U.S. biotech identified as One Bio, Jiangsu Hengrui Pharmaceutical Co. Ltd. has inked an out-licensing deal potentially worth $1.05 billion for its asthma and chronic sinusitis-targeting drug, SHR-1905. The latest deal gives One Bio exclusive rights to develop, produce and commercialize SHR-1905 worldwide, excluding the greater China territory.

With a U.S. biotech identified as One Bio, Jiangsu Hengrui Pharmaceutical Co. Ltd. has inked an out-licensing deal potentially worth $1.05 billion for its asthma and chronic sinusitis-targeting drug, SHR-1905. The latest deal gives One Bio exclusive rights to develop, produce and commercialize SHR-1905 worldwide, excluding the greater China territory.

Stock prices of multiple cancer drug companies soared Monday following the release of positive clinical trial results for their therapies at an ongoing industry conference in Chicago.

Stock prices of multiple cancer drug companies soared Monday following the release of positive clinical trial results for their therapies at an ongoing industry conference in Chicago.

Shares of several cancer drug firms surged in premarket trading on Monday after the companies reported positive clinical trial data from their therapies at an ongoing industry conference in Chicago. ... | June 5, 2023

(Reuters) - Shares of several cancer drug firms surged on Monday after the companies reported positive clinical trial data from their therapies at an ...

Shares of several cancer drug firms surged on Monday after the companies reported positive clinical trial data from their therapies at an ongoing industry conference in Chicago.

ONE Bio (OTCMKTS:ONBI – Get Rating) and Smart for Life (NASDAQ:SMFL – Get Rating) are both basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations. Earnings & Valuation This table compares ONE Bio […]

With temperatures set to hit the 30s again this week, it’s more important than ever to look after your skin